Radiotherapy administered postoperatively within 1 year of radical prostatectomy was associated with worse functional outcomes compared with radiotherapy administered 1 year or more after surgery.
Despite the increased risk, patients whose pancreatic cancer tumor has grown to encompass critical blood vessels can be candidates for surgery. Data on efforts to fine-tune a protocol for these patients were presented at the SSAT 57th Annual Meeting.
In women of reproductive age who have thyroid cancer, their remaining egg supply is affected by radioactive iodine treatment, potentially reducing their fertility.
Higher Treatment Volumes at Radiation Facilities Lead to Improved Overall Survival in Prostate CancerApril 06, 2016
Among men with aggressive prostate cancer, overall survival (OS) rates improve when they receive radiation treatment at facilities that frequently perform the treatment.
Survival rates are not increased and the likelihood of receiving a full course of radiation is decreased for patients with locally advanced head and neck cancer who receive IC rather than the standard treatment of CRT.
HPV Status Affects Conversion of Cancer Cells to Cancer Stem Cells in Head and Neck Squamous Cell CarcinomaMarch 03, 2016
Radiation treatment can transform head and neck cancer cells that survive the treatment into cancer stem cells that are resistant to radiation therapy, and this transformation is more prevalent when the cancer is HPV-negative.
Treating medulloblastoma with proton beam therapy results in survival rates in line with other proton therapies, according to recent study data.
An antiscarring paste halted the fibrosis caused by the radiation used in cancer therapy when applied to the skin of mice, according to early findings of a recent study.
Lung cancers with KRAS-related gene mutations might benefit from a triple therapy regimen of 2 experimental drugs plus radiation therapy.
Ten-year Overall Survival Is Higher After Breast-conserving Therapy Compared With Mastectomy in Early Stage Breast CancerDecember 10, 2015
Breast-conserving surgery with radiation therapy (BCT) demonstrated improved 10-year overall survival in patients with early stage breast cancer compared with mastectomy without radiation therapy, according to data presented at the 2015 San Antonio Breast Cancer Symposium.
Researchers showed that an increased risk of cardiovascular disease is quantified at specific dose levels of radiation as well as anthracycline exposure.
A radiotherapeutic bandage is being evaluated by researchers for efficacy against squamous cell carcinoma (SCC) in an animal model. Their results could confirm the viability of a new and improved strategy for the radiotherapeutic treatment of skin cancer in the clinic.
The cost of treatment for low-risk prostate cancer varies widely. A new study examined the cost of care from when a patient checks in for his first appointment through his posttreatment follow-up testing via the use of time-driven activity-based costing.
The search for evidence to support the growing use of proton therapy for more cancers continues to uncover valuable findings. New data from clinical trials demonstrate the potential advantages of proton therapy over conventional radiation for pancreatic cancer, late-stage non-small cell lung cancer, chordoma, and chondrosarcoma.
This fact sheet defines radon and reviews radon-related cancer risks.
Radiation to the lymph nodes as well as the standard treatment of whole-breast irradiation after breast-conserving surgery does not confer an overall survival benefit.
Early FDG-PET adapted treatment improves the outcome of early FDG-PET-positive patients with stages I/II Hodgkin lymphoma, according to the results of a randomized trial.
Two studies show benefits for hypofractionated versus conventionally fractionated whole-breast irradiation.
Higher radiation dose is associated with improved survival rates among men with medium- and high-risk prostate cancer.
Women diagnosed with breast cancer and treated with a one-week regimen of partial breast radiation after tumor removal saw no increase in cancer recurrence or difference in cosmetic outcomes.
Patients with an advanced form of metastatic non-small cell lung cancer (NSCLC) may benefit from surgical resection of all or part of the lung if combined with chemotherapy and radiation therapy.
New research indicates that treating patients with esophageal cancer with proton therapy produces fewer toxic side effects than utilizing older radiation therapies.
mFOLFOX6 administered concurrently with radiation therapy resulted in a higher pathological complete response in rectal cancer.
Cancer treatments in early life can lead to obesity in later years, and counseling and weight loss interventions for certain childhood cancer survivors are important.
Neck dissection of lymph nodes and treatment at academic or research institutions are both associated with improved survival for patients with stages I and II oral cavity squamous cell cancer, according to recent research.
Moderate exercise on a regular basis enhances tumor oxygenation, which may in turn improve treatment efficacy for cancer patients.
An investigation on the late side effects of a combination of two forms of brachytherapy to treat cervical cancer has revealed that the technique delivers higher radiation doses to the tumor without additional treatment-related complications afterwards.
Brachytherapy, with or without external beam radiation, can improve survival in women with inoperable, early stage endometrial cancer.
Three weeks after a multidimensional intervention, 90% of patients with head and neck cancer undergoing radiation reported full adherence.
Two studies do not show protective effect of delayed radiation compared to earlier radiation for prostate cancer.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- BBD Regimen Efficacious as First-line Therapy for Myeloma
- Some Early Breast Cancer Patients Should Have Breast Conservation Instead of Mastectomy
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Targeting AR Mutations Promising in Metastatic Prostate Cancer
- GUCS 2017: Early Immunotherapy Discontinuation in mRCC
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Myalgia-arthralgia Syndrome Associated With Taxanes in Patients with Breast Cancer
- Women Treated for DCIS Have Slightly Lower Risk for All-Cause Mortality
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|